- Home
- VIVS vs FTFT Comparison
VIVS vs FTFT Comparison
Compare VIVS & FTFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVS
- FTFT
- Stock Information
- Founded
- VIVS 2007
- FTFT N/A
- Country
- VIVS United States
- FTFT United States
- Employees
- VIVS N/A
- FTFT N/A
- Industry
- VIVS Biotechnology: Biological Products (No Diagnostic Substances)
- FTFT Business Services
- Sector
- VIVS Health Care
- FTFT Consumer Discretionary
- Exchange
- VIVS Nasdaq
- FTFT Nasdaq
- Market Cap
- VIVS 3.6M
- FTFT 3.9M
- IPO Year
- VIVS N/A
- FTFT N/A
- Fundamental
- Price
- VIVS $1.84
- FTFT $1.17
- Analyst Decision
- VIVS
- FTFT
- Analyst Count
- VIVS 0
- FTFT 0
- Target Price
- VIVS N/A
- FTFT N/A
- AVG Volume (30 Days)
- VIVS 71.5K
- FTFT 154.6K
- Earning Date
- VIVS 06-13-2025
- FTFT 05-20-2025
- Dividend Yield
- VIVS N/A
- FTFT N/A
- EPS Growth
- VIVS N/A
- FTFT N/A
- EPS
- VIVS N/A
- FTFT N/A
- Revenue
- VIVS $144,000.00
- FTFT $2,031,913.00
- Revenue This Year
- VIVS $59.08
- FTFT N/A
- Revenue Next Year
- VIVS $18.24
- FTFT N/A
- P/E Ratio
- VIVS N/A
- FTFT N/A
- Revenue Growth
- VIVS N/A
- FTFT N/A
- 52 Week Low
- VIVS $1.56
- FTFT $1.06
- 52 Week High
- VIVS $21.96
- FTFT $7.77
- Technical
- Relative Strength Index (RSI)
- VIVS N/A
- FTFT 35.84
- Support Level
- VIVS N/A
- FTFT $1.46
- Resistance Level
- VIVS N/A
- FTFT $1.57
- Average True Range (ATR)
- VIVS 0.00
- FTFT 0.14
- MACD
- VIVS 0.00
- FTFT -0.04
- Stochastic Oscillator
- VIVS 0.00
- FTFT 15.07
About VIVS VivoSim Labs Inc. Common Stock
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and cryptocurrency mining farm in the U.S. The company's reportable segments include the Supply chain financing/trading segment which generates key revenue, and the Asset management service segment.